Carr Patricia — SEC Form 4 filings
SEC reporting owner CIK 1784606. 13 Form 4 filings on record with FilingPulse; latest filed 2026-03-09.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-01-19 to 2026-03-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 16 legs across 9 filings — 24,282 shares, $3,883,719 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 18.
- Largest priced transaction: sale of 5,250 shares @ $182.07 ($955,868) in Jazz Pharmaceuticals plc, filed 2025-11-20.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Jazz Pharmaceuticals plc (JAZZ) | SVP, Chief Accounting Officer | 13 | — | 16 legs · 24,282 sh · $3,883,719 | 18 |
Form 4 filings — Carr Patricia
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-09 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Tax withholding (F): 1,436 @ $186.77 · Sale (S): 1,287 @ $182.94 | EDGAR |
| 2026-03-02 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 2,223 @ $0 · Sale (S): 1,253 @ $194.11 · Sale (S): 1,117 @ $190.91 | EDGAR |
| 2026-01-21 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 2,370 @ $0 | EDGAR |
| 2025-12-09 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 160 @ $171.11 · Option exercise (M): 4,500 @ $140.67 · Sale (S): 4,500 @ $171.20 · Option exercise (M): 4,500 (derivative) @ $0 | EDGAR |
| 2025-11-20 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 69 @ $181.66 · Option exercise (M): 5,250 @ $136.18 · Sale (S): 5,250 @ $182.07 · Option exercise (M): 5,250 (derivative) @ $0 | EDGAR |
| 2025-03-11 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Disposition to issuer (D): 1,333 @ $138.23 · Sale (S): 1,140 @ $137.81 | EDGAR |
| 2025-03-03 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Option exercise (M): 4,500 @ $113.10 · Sale (S): 4,500 @ $144.42 · Option exercise (M): 313 @ $123.36 · Sale (S): 313 @ $144.42 · Disposition to issuer (D): 371 @ $142.43 · Disposition to issuer (D): 497 @ $142.43 · +4 more | EDGAR |
| 2025-01-22 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 1,641 @ $0 | EDGAR |
| 2024-12-04 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 53 @ $122.49 | EDGAR |
| 2024-06-11 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 163 @ $108.83 | EDGAR |
| 2024-03-08 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 1,236 @ $120.85 · Sale (S): 700 @ $117.51 · Sale (S): 1,768 @ $116.98 | EDGAR |
| 2024-03-05 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 2,987 @ $0 | EDGAR |
| 2024-01-19 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 1,327 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1784606 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →